| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,596 |
24,885 |
$3.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,841 |
21,733 |
$1.83M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,126 |
5,916 |
$752K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,698 |
5,556 |
$711K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,606 |
5,525 |
$605K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,909 |
3,850 |
$454K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
17,282 |
16,832 |
$263K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,398 |
5,474 |
$78K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,948 |
4,731 |
$71K |
| 99381 |
|
664 |
598 |
$59K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,691 |
7,231 |
$44K |
| 99215 |
Prolong outpt/office vis |
122 |
120 |
$19K |
| 85018 |
|
18,884 |
18,396 |
$12K |
| 81003 |
|
10,487 |
10,035 |
$10K |
| 99383 |
|
81 |
81 |
$9K |
| 86580 |
|
3,922 |
3,848 |
$9K |
| 83655 |
|
1,981 |
1,932 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,232 |
3,106 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
37 |
33 |
$5K |
| 0071A |
|
118 |
106 |
$3K |
| 90710 |
|
1,241 |
1,208 |
$2K |
| 0072A |
|
50 |
50 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
418 |
392 |
$1K |
| 90680 |
|
2,956 |
2,883 |
$1K |
| 90633 |
|
2,201 |
2,104 |
$663.10 |
| 90686 |
|
4,725 |
4,617 |
$637.89 |
| 0003A |
|
16 |
16 |
$434.92 |
| 90671 |
|
1,301 |
1,272 |
$222.61 |
| 90656 |
|
345 |
343 |
$200.08 |
| 36416 |
|
16,879 |
16,419 |
$158.44 |
| G0008 |
Administration of influenza virus vaccine |
14 |
14 |
$103.32 |
| 90651 |
|
1,107 |
1,083 |
$35.00 |
| 90700 |
|
336 |
321 |
$28.82 |
| 90734 |
|
1,137 |
1,115 |
$24.01 |
| 90648 |
|
4,469 |
4,331 |
$12.93 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,002 |
1,943 |
$6.40 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
415 |
386 |
$4.47 |
| 91307 |
|
183 |
169 |
$0.26 |
| 90715 |
|
315 |
312 |
$0.12 |
| 91300 |
|
39 |
39 |
$0.10 |
| 90696 |
|
348 |
333 |
$0.04 |
| 90723 |
|
3,452 |
3,342 |
$0.00 |
| 96127 |
|
1,263 |
1,242 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,453 |
3,301 |
$0.00 |
| 90620 |
|
365 |
358 |
$0.00 |
| 90716 |
|
30 |
30 |
$0.00 |
| 90670 |
|
2,990 |
2,901 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
439 |
414 |
$0.00 |
| 99173 |
|
13 |
13 |
$0.00 |
| 90707 |
|
57 |
57 |
$0.00 |
| 90685 |
|
34 |
34 |
$0.00 |